Article Text

Download PDFPDF
Differential expression of laminin receptors in human hepatocellular carcinoma
  1. I Ozaki,
  2. K Yamamoto,
  3. T Mizuta,
  4. S Kajihara,
  5. N Fukushima,
  6. Y Setoguchi,
  7. F Morito,
  8. T Sakai
  1. Division of Hepatology and Metabolism, Department of Internal Medicine, Saga Medical School, Saga, Japan
  1. Dr I Ozaki, Division of Hepatology and Metabolism, Department of Internal Medicine, Saga Medical School, 5–1–1 Nabeshima, Saga 849, Japan.


Background—Laminin receptors are involved in cell-extracellular matrix interactions in malignant cells that show invasion and metastasis. Hepatocellular carcinoma frequently shows early invasion into blood vessels, and intrahepatic and extrahepatic metastases. However, the role of laminin receptors in hepatocellular carcinoma is unknown.

Aims—To examine the expression of mRNA for laminin receptors and their isoforms in hepatocellular carcinoma.

Methods—The expression of several laminin receptors, including α1 integrin, α6 integrin and its isoforms α6A and α6B, β1 integrin and its isoforms β1A and β1B, and 32kD/67kDa laminin binding protein was examined in human hepatocellular carcinomas and non-cancerous liver tissues using the reverse transcription polymerase chain reaction.

Results—α6 Integrin, β1 integrin, and laminin binding protein showed notably increased expression in hepatocellular carcinoma, compared with non-cancerous liver tissue, although the α1 integrin did not show a significant change. Furthermore, β1B integrin, a splicing variant of β1 integrin, was overexpressed in hepatocellular carcinoma while the β1A integrin isoform did not show significant changes between hepatocellular carcinoma and surrounding non-cancerous liver tissue.

Conclusions—The differential upregulation of laminin receptors and their splicing isoforms was shown in hepatocellular carcinoma, suggesting that certain laminin receptors and their isoforms may be involved in the development and progression of hepatocellular carcinoma.

  • laminin receptor
  • integrin α6β1
  • hepatocellular carcinoma

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.